Found: 11
Select item for more details and to access through your institution.
Patients of 75 years and over with ANCA‐associated vasculitis have a lower relapse risk than younger patients: A multicentre cohort study.
- Published in:
- Journal of Internal Medicine, 2022, v. 291, n. 3, p. 350, doi. 10.1111/joim.13417
- By:
- Publication type:
- Article
Discovery and validation of a transcriptional signature identifying homologous recombination-deficient breast, endometrial and ovarian cancers.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Clinical assessment of the miR-34, miR-200, ZEB1 and SNAIL EMT regulation hub underlines the differential prognostic value of EMT miRs to drive mesenchymal transition and prognosis in resected NSCLC.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Overall Survival Prediction and Usefulness of Second-Line Chemotherapy in Advanced Pancreatic Adenocarcinoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
External Validity of Two Scores for Predicting the Risk of Chemotherapy Toxicity Among Older Patients With Solid Tumors: Results From the ELCAPA Prospective Cohort.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. e341, doi. 10.1093/oncolo/oyad050
- By:
- Publication type:
- Article
Brain Metastases and Place of Antiangiogenic Therapies in Alveolar Soft Part Sarcoma: A Retrospective Analysis of the French Sarcoma Group.
- Published in:
- Oncologist, 2019, v. 24, n. 7, p. 980, doi. 10.1634/theoncologist.2018-0074
- By:
- Publication type:
- Article
Highly Specific Droplet-Digital PCR Detection of Universally Methylated Circulating Tumor DNA in Endometrial Carcinoma.
- Published in:
- Clinical Chemistry, 2022, v. 68, n. 6, p. 782, doi. 10.1093/clinchem/hvac020
- By:
- Publication type:
- Article
The NRF2 transcriptional target NQO1 has low mRNA levels in TP53-mutated endometrial carcinomas.
- Published in:
- PLoS ONE, 2019, v. 14, n. 3, p. 1, doi. 10.1371/journal.pone.0214416
- By:
- Publication type:
- Article
Association between Olaparib Exposure and Early Toxicity in BRCA-Mutated Ovarian Cancer Patients: Results from a Retrospective Multicenter Study.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 8, p. 804, doi. 10.3390/ph14080804
- By:
- Publication type:
- Article
Improving olaparib exposure to optimize adverse effects management.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, v. 16, p. 1, doi. 10.1177/17588359241248328
- By:
- Publication type:
- Article
A novel Chr1-miR-200 driven whole transcriptome signature shapes tumor immune microenvironment and predicts relapse in early-stage lung adenocarcinoma.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04086-7
- By:
- Publication type:
- Article